Furthermore, Wang et al. elucidated that selective repression of mTORC1 in ECs with an mTORC1 inhibitor, RAD001, contributed to tumour vascular normalisation and further enhanced immune response with elevated CD103+ DC infiltration [143]. Here, ITGAE is linked to neoplasm.